MetaADEDB 2.0 @ LMMD
Cefotetan
(ZQQALMSFFARWPK-ZTQQJVKJSA-L)
Structure
SMILES
CO[C@@]1(NC(=O)C2SC(=C(C(=O)N)C(=O)[O-])S2)C(=O)N2[C@@H]1SCC(=C2C(=O)[O-])CSc1nnnn1C.[Na+].[Na+]
Molecular Formula:
C17H15N7Na2O8S4
Molecular Weight:
619.583
Log P:
-3.0378
Hydrogen Bond Acceptor:
19
Hydrogen Bond Donor:
2
TPSA:
326.79
CAS Number(s):
74356-00-6
Synonym(s)
1.
Cefotetan
2.
Apacef
3.
Apatef
4.
Cefotan
5.
Cefotetan Disodium
6.
Cefotetan Disodium Salt
7.
Ceftotan
8.
ICI-156834
9.
YM-09330
10.
Disodium Salt, Cefotetan
11.
Disodium, Cefotetan
12.
ICI 156834
13.
ICI156834
14.
Salt, Cefotetan Disodium
15.
YM 09330
16.
YM09330
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1UrticariaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Abdominal PainFAERS: 1US FAERS
3Anaphylactic shockFAERS: 1US FAERS
4Burning sensationFAERS: 1US FAERS
5Chest discomfortFAERS: 1US FAERS
6Drug exposure during pregnancyFAERS: 1US FAERS
7ErythemaFAERS: 1US FAERS
8FibromyalgiaFAERS: 1US FAERS
9FlushingFAERS: 1US FAERS
10HypotensionFAERS: 1US FAERS
11HypoxiaFAERS: 1US FAERS
12Maternal exposure timing unspecifiedFAERS: 1US FAERS
13NauseaFAERS: 1US FAERS
14PruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Respiratory distressFAERS: 1US FAERS
16ThrombocytopeniaFAERS: 1US FAERS
17VomitingFAERS: 1US FAERS
18ArthralgiaCanada Vigilance: 1Canada Vigilance
19Aspartate Aminotransferase IncreasedCanada Vigilance: 1Canada Vigilance
20Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
21DizzinessCanada Vigilance: 1Canada Vigilance
22SyncopeCanada Vigilance: 1Canada Vigilance
23Visual ImpairmentCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.